These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 15137882)
1. Management and costs of treating lung cancer patients in a university hospital. Dedes KJ; Szucs TD; Bodis S; Joerger M; Lowy A; Russi EW; Steinert HC; Weder W; Stahel RA Pharmacoeconomics; 2004; 22(7):435-44. PubMed ID: 15137882 [TBL] [Abstract][Full Text] [Related]
2. Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain). Corral J; Espinàs JA; Cots F; Pareja L; Solà J; Font R; Borràs JM BMC Health Serv Res; 2015 Feb; 15():70. PubMed ID: 25889153 [TBL] [Abstract][Full Text] [Related]
3. Cost analysis of lung cancer management in South Western Sydney. Kang S; Koh ES; Vinod SK; Jalaludin B J Med Imaging Radiat Oncol; 2012 Apr; 56(2):235-41. PubMed ID: 22498199 [TBL] [Abstract][Full Text] [Related]
4. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis. Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377 [TBL] [Abstract][Full Text] [Related]
5. A cost calculation model for specialist palliative care for patients with non-small cell lung cancer in a tertiary centre. Ostgathe C; Walshe R; Wolf J; Hallek M; Voltz R Support Care Cancer; 2008 May; 16(5):501-6. PubMed ID: 17909863 [TBL] [Abstract][Full Text] [Related]
6. Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages? Türk M; Yıldırım F; Yurdakul AS; Öztürk C Tuberk Toraks; 2016 Dec; 64(4):263-268. PubMed ID: 28393715 [TBL] [Abstract][Full Text] [Related]
7. Changing costs of metastatic non small cell lung cancer in the Netherlands. Keusters WR; de Weger VA; Hövels A; Schellens JHM; Frederix GWJ Lung Cancer; 2017 Dec; 114():56-61. PubMed ID: 29173766 [TBL] [Abstract][Full Text] [Related]
8. Direct treatment costs for patients with lung cancer from first recurrence to death in france. Braud AC; Lévy-Piedbois C; Piedbois P; Piedbois Y; Livartovski A; Le Vu B; Trédaniel J; Reboul F; Brewer Y; Talbi S; Blanchon F; Paschen B; Durand-Zaleski I Pharmacoeconomics; 2003; 21(9):671-9. PubMed ID: 12807368 [TBL] [Abstract][Full Text] [Related]
9. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands. Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601 [TBL] [Abstract][Full Text] [Related]
10. Direct medical cost associated with colorectal cancer in north of Jordan. Alefan Q; Malhees R; Mhaidat N Curr Probl Cancer; 2017; 41(5):371-381. PubMed ID: 28629637 [TBL] [Abstract][Full Text] [Related]
11. Cost of care for lung cancer in the first year after diagnosis in Iran. Mohagheghi MA; Mousavi-Jarrahi Y; Mosavi-Jarrahi A Asian Pac J Cancer Prev; 2011; 12(4):1013-5. PubMed ID: 21790243 [TBL] [Abstract][Full Text] [Related]
12. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer. Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264 [TBL] [Abstract][Full Text] [Related]
13. Treatment pathways, resource use and costs in the management of small cell lung cancer. Oliver E; Killen J; Kiebert G; Hutton J; Hall R; Higgins B; Bourke S; Paschen B Thorax; 2001 Oct; 56(10):785-90. PubMed ID: 11562518 [TBL] [Abstract][Full Text] [Related]
14. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study. Naito T; Okayama T; Aoyama T; Ohashi T; Masuda Y; Kimura M; Shiozaki H; Murakami H; Kenmotsu H; Taira T; Ono A; Wakuda K; Imai H; Oyakawa T; Ishii T; Omori S; Nakashima K; Endo M; Omae K; Mori K; Yamamoto N; Tanuma A; Takahashi T BMC Cancer; 2017 Nov; 17(1):800. PubMed ID: 29183277 [TBL] [Abstract][Full Text] [Related]
16. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model. Evans WK; Will BP; Berthelot JM; Wolfson MC Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457 [TBL] [Abstract][Full Text] [Related]
17. Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden. Guérin A; Sasane M; Zhang J; Culver KW; Dea K; Nitulescu R; Wu EQ J Med Econ; 2015 Apr; 18(4):312-22. PubMed ID: 25565443 [TBL] [Abstract][Full Text] [Related]
18. [The impacts of the multidisciplinary team model on the length of stay and hospital expenses of patients with lung cancer]. Zou J; Xu X; Wang D; Xu J; Gu W Zhonghua Jie He He Hu Xi Za Zhi; 2015 May; 38(5):370-4. PubMed ID: 26463490 [TBL] [Abstract][Full Text] [Related]
19. Costs of non-small cell lung cancer in the Netherlands. van der Linden N; Bongers ML; Coupé VM; Smit EF; Groen HJ; Welling A; Schramel FM; Uyl-de Groot CA Lung Cancer; 2016 Jan; 91():79-88. PubMed ID: 26589654 [TBL] [Abstract][Full Text] [Related]
20. Acute coronary syndromes in Europe: 1-year costs and outcomes. Taylor MJ; Scuffham PA; McCollam PL; Newby DE Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]